Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9114)
All Articles published online
|
Publishing Process of This Article
|
Mar 28, 2014 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zenlea T, Peppercorn MA. Immunosuppressive therapies for inflammatory bowel disease. World J Gastroenterol 2014; 20(12): 3146-3152 [PMID: 24696600 DOI: 10.3748/wjg.v20.i12.3146] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i12/3146.htm |
| Number | Citing Articles |
| 1 |
Maitham Abbas Khajah. The potential role of fecal microbiota transplantation in the treatment of inflammatory Bowel disease. Scandinavian Journal of Gastroenterology 2017; 52(11): 1172 doi: 10.1080/00365521.2017.1347812
|
| 2 |
Priyanka Vashisht, James O’dell. Not all TNF inhibitors in rheumatoid arthritis are created equal: important clinical differences. Expert Opinion on Biological Therapy 2017; 17(8): 989 doi: 10.1080/14712598.2017.1340453
|
| 3 |
Shuang Yan, Bo Yang, Jichun Zhao, Jianxin Zhao, Catherine Stanton, R. Paul Ross, Hao Zhang, Wei Chen. A ropy exopolysaccharide producing strainBifidobacterium longumsubsp.longumYS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation. Food & Function 2019; 10(3): 1595 doi: 10.1039/C9FO00014C
|
| 4 |
Zhen-Ping Zou, Xiao-Peng Zhang, Qian Zhang, Bin-Cheng Yin, Ying Zhou, Bang-Ce Ye. Genetically engineered bacteria as inflammatory bowel disease therapeutics. Engineering Microbiology 2024; 4(4): 100167 doi: 10.1016/j.engmic.2024.100167
|
| 5 |
Yu Li, Hengyi Yan, Xiaoman Xu, Hongbo Liu, Cen Wu, Li Zhao. Erastin/sorafenib induces cisplatin‑resistant non‑small cell lung cancer cell ferroptosis through inhibition of the Nrf2/xCT pathway. Oncology Letters 2019; doi: 10.3892/ol.2019.11066
|
| 6 |
Dandan Liu, Varma Saikam, Katie A. Skrada, Didier Merlin, Suri S. Iyer. Inflammatory bowel disease biomarkers. Medicinal Research Reviews 2022; 42(5): 1856 doi: 10.1002/med.21893
|
| 7 |
Victor O Adedara, Charles A Adedara, Nicola D Ruth, Grant U Alozie, Nate Nettagul. Advancements in the Management of Pediatric and Adult Inflammatory Bowel Disease: A Systematic Review of Treatment Strategies and Long-Term Outcomes. Cureus 2024; doi: 10.7759/cureus.72324
|
| 8 |
Triet M. Bui, Ronen Sumagin. Progressing from Recurring Tissue Injury to Genomic Instability: A New Mechanism of Neutrophil Pathogenesis. DNA and Cell Biology 2019; 38(8): 747 doi: 10.1089/dna.2019.4842
|
| 9 |
Karuppusamy Arunachalam, Amilcar Sabino Damazo, Antonio Macho, Joaquim Corsino da Silva Lima, Eduarda Pavan, Fabiana de Freitas Figueiredo, Darley Maria Oliveira, Valdir Cechinel-Filho, Theodoro Marcel Wagner, Domingos Tabajara de Oliveira Martins. Piper umbellatum L. (Piperaceae): Phytochemical profiles of the hydroethanolic leaf extract and intestinal anti-inflammatory mechanisms on 2,4,6 trinitrobenzene sulfonic acid induced ulcerative colitis in rats. Journal of Ethnopharmacology 2020; 254: 112707 doi: 10.1016/j.jep.2020.112707
|
| 10 |
Byung-Hee Lee, Jiyoon Won, Hyangsook Lee. Herbal Medicine Treatment for Induction and Maintenance of Remission in Ulcerative Colitis: A Case Report. Korean Journal of Acupuncture 2019; 36(3): 181 doi: 10.14406/acu.2019.014
|
| 11 |
Suguru Shigemori, Takeshi Shimosato. Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00022
|
| 12 |
George Kottakis, Katerina Kambouri, Alexandra Giatromanolaki, Georgia Valsami, Nikolaos Kostomitsopoulos, Alexandra Tsaroucha, Michael Pitiakoudis. Effects of the Antioxidant Quercetin in an Experimental Model of Ulcerative Colitis in Mice. Medicina 2022; 59(1): 87 doi: 10.3390/medicina59010087
|
| 13 |
Hee Seung Hong, Jiwon Jung, Sang Hyoung Park, Hwa Jung Kim, Sung Wook Hwang, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye. Seroprevalence of viral infectious diseases and associated factors in Korean patients with inflammatory bowel diseases. The Korean Journal of Internal Medicine 2022; 37(1): 73 doi: 10.3904/kjim.2020.386
|
| 14 |
Shailesh Perdalkar, Pooja Basthi Mohan, Balaji Musunuri, Siddheesh Rajpurohit, Shiran Shetty, Krishnamurthy Bhat, Cannanore Ganesh Pai. Thiopurine therapy in inflammatory bowel disease in the pandemic era: Safe or unsafe?. International Immunopharmacology 2023; 116: 109597 doi: 10.1016/j.intimp.2022.109597
|
| 15 |
Sruthi Vijaya Retnakumar, Sylviane Muller. Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel Diseases. Trends in Molecular Medicine 2019; 25(6): 516 doi: 10.1016/j.molmed.2019.03.002
|
| 16 |
Ming-zhe Ma, Gang Chen, Peng Wang, Wen-hua Lu, Chao-feng Zhu, Ming Song, Jing Yang, Shijun Wen, Rui-hua Xu, Yumin Hu, Peng Huang. Xc− inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism. Cancer Letters 2015; 368(1): 88 doi: 10.1016/j.canlet.2015.07.031
|
| 17 |
Andreas Stallmach, Carsten Schmidt, Niels Teich. Vedolizumab for the treatment of ulcerative colitis. Expert Review of Gastroenterology & Hepatology 2016; 10(2): 165 doi: 10.1586/17474124.2016.1123618
|
| 18 |
Séverine Vermeire, Silvio Danese, William J Sandborn, Stefan Schreiber, Stephen Hanauer, Geert D’Haens, Peter Nagy, Manoj Thakur, Caleb Bliss, Fabio Cataldi, Martina Goetsch, Kenneth J Gorelick, Walter Reinisch. Efficacy and Safety of the Anti-mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn’s Disease. Journal of Crohn's and Colitis 2024; 18(5): 708 doi: 10.1093/ecco-jcc/jjad199
|
| 19 |
Amélia Sarmento, Catarina D. Simões. Comprehensive Gut Microbiota. 2022; : 423 doi: 10.1016/B978-0-12-819265-8.00057-7
|
| 20 |
Fabio Salvatore Macaluso, Sara Renna, Ambrogio Orlando, Mario Cottone. The biologics of ulcerative colitis. Expert Opinion on Biological Therapy 2017; 17(2): 175 doi: 10.1080/14712598.2017.1271871
|
| 21 |
Dagmar Srutkova, Martin Schwarzer, Tomas Hudcovic, Zuzana Zakostelska, Vladimir Drab, Alena Spanova, Bohuslav Rittich, Hana Kozakova, Irma Schabussova, Mathias Chamaillard. Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner. PLOS ONE 2015; 10(7): e0134050 doi: 10.1371/journal.pone.0134050
|
| 22 |
Jaya D. Prasad, Katherine C. Gunn, Joanne O. Davidson, Robert Galinsky, Scott E. Graham, Mary J. Berry, Laura Bennet, Alistair J. Gunn, Justin M. Dean. Anti-Inflammatory Therapies for Treatment of Inflammation-Related Preterm Brain Injury. International Journal of Molecular Sciences 2021; 22(8): 4008 doi: 10.3390/ijms22084008
|
| 23 |
Bob Meek, Marcel P. H. van den Broek, Anouk C. M. Platteel. Biologicals: spectrum en targets. Bijblijven 2018; 34(2): 93 doi: 10.1007/s12414-018-0283-9
|
| 24 |
Chenfan Duan, Yanzhuo Liu, Ying Li, Honglei Chen, Xiaoxiao Liu, Xuewei Chen, Jiang Yue, Xiaoyang Zhou, Jing Yang. Sulfasalazine alters microglia phenotype by competing endogenous RNA effect of miR-136-5p and long non-coding RNA HOTAIR in cuprizone-induced demyelination. Biochemical Pharmacology 2018; 155: 110 doi: 10.1016/j.bcp.2018.06.028
|
| 25 |
Luisa Castro Laria, Federico Argüelles Arias, Valle García Sánchez, José Manuel Benítez, Ramón Fernández Pérez, Ana María Trapero Fernández, Francisco Gallardo Sánchez, Héctor Pallarés Manrique, María Gómez García, María José Cabello Tapia, Aurora Talavera Fabuel, Ana Bejarano García, Eduardo Leo Carnerero, Álvaro Hernández Martínez, Ángel Caunedo Álvarez, Juan Manuel Herrerías-Gutiérrez. Initial experience with golimumab in clinical practice for ulcerative colitis. Revista Española de Enfermedades Digestivas 2016; doi: 10.17235/reed.2016.4068/2015
|
| 26 |
Tao Zhang, Jindong Zhang, Liping Duan. The Role of Genetically Engineered Probiotics for Treatment of Inflammatory Bowel Disease: A Systematic Review. Nutrients 2023; 15(7): 1566 doi: 10.3390/nu15071566
|
| 27 |
Chara Litou, Angela Effinger, Edmund S Kostewicz, Karl J Box, Nikoletta Fotaki, Jennifer B Dressman. Effects of medicines used to treat gastrointestinal diseases on the pharmacokinetics of coadministered drugs: a PEARRL Review. Journal of Pharmacy and Pharmacology 2019; 71(4): 643 doi: 10.1111/jphp.12983
|
| 28 |
Cindy CY Law, Deborah Koh, Yueyang Bao, Vipul Jairath, Neeraj Narula. Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease. Cochrane Database of Systematic Reviews 2019; doi: 10.1002/14651858.CD013256
|
| 29 |
Mati Ur Rehman, Paras Jawaid, Qing-Li Zhao, Takashi Kondo, Jun-ichi Saitoh, Kyo Noguchi. Physical and chemical enhancement of cancer cell death induced by cold atmospheric plasma. Japanese Journal of Applied Physics 2021; 60(3): 030501 doi: 10.35848/1347-4065/abde55
|
| 30 |
Anthony E. Seddio, Beatrice M. Katsnelson, Julian Smith-Voudouris, Michael J. Gouzoulis, Wesley Day, Sahir S. Jabbouri, Rajiv S. Vasudevan, Daniel R. Rubio, Jonathan N. Grauer. Inflammatory bowel disease is associated with greater odds of complications following posterior lumbar fusion and further amplified for patients exposed to biologics. North American Spine Society Journal (NASSJ) 2024; : 100574 doi: 10.1016/j.xnsj.2024.100574
|
| 31 |
Piotr Leonczak, Ling‐Jie Gao, Anna Teresa Ramadori, Eveline Lescrinier, Jef Rozenski, Steven De Jonghe, Piet Herdewijn. Synthesis and Structure–Activity Relationship Studies of 2‐(1,3,4‐Oxadiazole‐2(3H)‐thione)‐3‐amino‐5‐arylthieno[2,3‐b]pyridines as Inhibitors of DRAK2. ChemMedChem 2014; 9(11): 2587 doi: 10.1002/cmdc.201402234
|
| 32 |
Laurent Peyrin-Biroulet, Yoram Bouhnik, Xavier Roblin, Guillaume Bonnaud, Hervé Hagège, Xavier Hébuterne. French national consensus clinical guidelines for the management of Crohn’s disease. Digestive and Liver Disease 2017; 49(4): 368 doi: 10.1016/j.dld.2016.12.008
|
| 33 |
In-Gyu Je, Don-Gil Lee, Dong-Gu Jeong, Dahae Hong, Jong-Min Yoon, Jin Seok Moon, Soobong Park. The Probiotic, ID-JPL934, Attenuates Dextran Sulfate Sodium-Induced Colitis in Mice Through Inhibition of Proinflammatory Cytokines Expression. Journal of Medicinal Food 2018; 21(9): 858 doi: 10.1089/jmf.2017.4152
|
| 34 |
Qiyu Tian, Zhixin Xu, Qi Sun, Alejandro Bravo Iniguez, Min Du, Mei-Jun Zhu. Broccoli-Derived Glucoraphanin Activates AMPK/PGC1α/NRF2 Pathway and Ameliorates Dextran-Sulphate-Sodium-Induced Colitis in Mice. Antioxidants 2022; 11(12): 2404 doi: 10.3390/antiox11122404
|
| 35 |
Alessandro Armuzzi, Paolo Gionchetti, Marco Daperno, Silvio Danese, Ambrogio Orlando, Maria Lia Scribano, Maurizio Vecchi, Fernando Rizzello, Sandro Ardizzone, Alessandro Armuzzi, Fabiana Castiglione, Silvio Danese, Marco Daperno, Massimo Fantini, Gionata Fiorino, Giuseppe Frieri, Paolo Gionchetti, Luca Neri, Ambrogio Orlando, Fernando Rizzello, Maria Lia Scribano, Giacomo Carlo Sturniolo, Maurizio Vecchi. Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease. Digestive and Liver Disease 2016; 48(4): 360 doi: 10.1016/j.dld.2015.12.016
|
| 36 |
Faraza Javed, Qaiser Jabeen. Salsola imbricata Forssk. ameliorates acetic acid-induced inflammatory bowel disease by modulating dysregulated antioxidant enzyme system and cytokine signaling pathways in mice. Asian Pacific Journal of Tropical Biomedicine 2021; 11(12): 527 doi: 10.4103/2221-1691.331268
|
| 37 |
Roxana Chis, Prameet M. Sheth, Elaine O. Petrof. Mechanisms Underlying Host-Microbiome Interactions in Pathophysiology of Human Diseases. 2018; : 279 doi: 10.1007/978-1-4939-7534-1_11
|
| 38 |
Jiyoon Won, Byung-Hee Lee, Won-Mo Jung, Younbyoung Chae, Hyangsook Lee. Herbal medicine for inflammatory bowel diseases: development of pattern identification algorithms by retrospective analysis of case series data. European Journal of Integrative Medicine 2020; 36: 101114 doi: 10.1016/j.eujim.2020.101114
|
| 39 |
Samuel Fernández-Tomé, Lourdes Amigo, Cristina Martínez-Villaluenga, Blanca Hernández-Ledesma. Current Advances for Development of Functional Foods Modulating Inflammation and Oxidative Stress. 2022; : 517 doi: 10.1016/B978-0-12-823482-2.00027-3
|
| 40 |
Antonio López-Sanromán, Juan V. Esplugues, Eugeni Domènech. Pharmacology and safety of tofacitinib in ulcerative colitis. Gastroenterología y Hepatología (English Edition) 2021; 44(1): 39 doi: 10.1016/j.gastre.2020.04.007
|
| 41 |
Hee-Young Kim, Hyongjun Jeon, Chang Hwan Bae, Yukyoung Lee, Hyungwoo Kim, Seungtae Kim. Rumex japonicus Houtt. alleviates dextran sulfate sodium-induced colitis by protecting tight junctions in mice. Integrative Medicine Research 2020; 9(2): 100398 doi: 10.1016/j.imr.2020.02.006
|
| 42 |
Katlyn M. Smaha, Silas M. Money, Loretta S. Davis. Review of dermatologic drugs relevant to inflammatory bowel disease. JAAD Reviews 2024; 1: 65 doi: 10.1016/j.jdrv.2024.07.001
|
| 43 |
X.L. Wang, J. Zhao, L. Qin, M. Qiao. Promoting inflammatory lymphangiogenesis by vascular endothelial growth factor-C (VEGF-C) aggravated intestinal inflammation in mice with experimental acute colitis. Brazilian Journal of Medical and Biological Research 2016; 49(5) doi: 10.1590/1414-431x20154738
|
| 44 |
Obaid Afzal, Abdulmalik S. A. Altamimi, Bismillah Mubeen, Sami I. Alzarea, Waleed Hassan Almalki, Salwa D. Al-Qahtani, Eman M. Atiya, Fahad A. Al-Abbasi, Fatima Ali, Inam Ullah, Muhammad Shahid Nadeem, Imran Kazmi. mTOR as a Potential Target for the Treatment of Microbial Infections, Inflammatory Bowel Diseases, and Colorectal Cancer. International Journal of Molecular Sciences 2022; 23(20): 12470 doi: 10.3390/ijms232012470
|
| 45 |
Koichiro Ogihara, Eiji Kikuchi, Shogo Okazaki, Masayuki Hagiwara, Toshikazu Takeda, Kazuhiro Matsumoto, Takeo Kosaka, Shuji Mikami, Hideyuki Saya, Mototsugu Oya. Sulfasalazine could modulate the CD44v9‐xCT system and enhance cisplatin‐induced cytotoxic effects in metastatic bladder cancer. Cancer Science 2019; 110(4): 1431 doi: 10.1111/cas.13960
|
| 46 |
Urara Idei, Tsuyoshi Ohta, Hizuru Yamatani, Manabu Seino, Satoru Nagase. Mechanism of Cell Death by Combined Treatment with an xCT Inhibitor and Paclitaxel: An Alternative Therapeutic Strategy for Patients with Ovarian Clear Cell Carcinoma. International Journal of Molecular Sciences 2023; 24(14): 11781 doi: 10.3390/ijms241411781
|
| 47 |
Jagadeesh Nagendra Manda, Milica Markovic, Ellen M. Zimmermann, Shimon Ben‐Shabat, Arik Dahan, Aaron Aponick. Phospholipid Cyclosporine Prodrugs Targeted at Inflammatory Bowel Disease (IBD) Treatment: Design, Synthesis, and in Vitro Validation. ChemMedChem 2020; 15(17): 1639 doi: 10.1002/cmdc.202000317
|
| 48 |
Giuseppe Murdaca, Monica Greco, Matteo Borro, Sebastiano Gangemi. Hygiene hypothesis and autoimmune diseases: A narrative review of clinical evidences and mechanisms. Autoimmunity Reviews 2021; 20(7): 102845 doi: 10.1016/j.autrev.2021.102845
|
| 49 |
Anthony F Juritsch, Régis Moreau. Role of soybean-derived bioactive compounds in inflammatory bowel disease. Nutrition Reviews 2018; 76(8): 618 doi: 10.1093/nutrit/nuy021
|
| 50 |
Fahimeh Sadat Gholam-Mostafaei, Abbas Yadegar, Hamid Asadzadeh Aghdaei, Masoumeh Azimirad, Nasser Ebrahimi Daryani, Mohammad Reza Zali. Anti-TNF containing regimens may be associated with increased risk of Clostridioides difficile infection in patients with underlying inflammatory bowel disease. Current Research in Translational Medicine 2020; 68(3): 125 doi: 10.1016/j.retram.2020.03.002
|
| 51 |
Yuichi Tasaka, Daiki Yasunaga, Takeshi Kiyoi, Mamoru Tanaka, Akihiro Tanaka, Katsuya Suemaru, Hiroaki Araki. Involvement of stimulation of α7 nicotinic acetylcholine receptors in the suppressive effect of tropisetron on dextran sulfate sodium-induced colitis in mice. Journal of Pharmacological Sciences 2015; 127(3): 275 doi: 10.1016/j.jphs.2014.12.016
|
| 52 |
Shu Yan Li, Pei Wei Li, Bo Shen, Min Zhi, Yu Bei Gu, Xin Ying Wang, Hong Guo, Yue Li, Yi Hong Fan, Bo Lin Yang, Meng Xue, Xiao Ying Wang, Min Fang Lv, Yan Li, Bin Ye, Xin Jian Zhu, Yan Chen. Insufficient awareness and vaccination practices for inflammatory bowel disease patients in China: A multi‐center survey of Chinese gastroenterologists. Journal of Digestive Diseases 2020; 21(1): 46 doi: 10.1111/1751-2980.12834
|
| 53 |
Héla Mkaouar, Vincent Mariaule, Soufien Rhimi, Juan Hernandez, Aicha Kriaa, Amin Jablaoui, Nizar Akermi, Emmanuelle Maguin, Adam Lesner, Brice Korkmaz, Moez Rhimi. Gut Serpinome: Emerging Evidence in IBD. International Journal of Molecular Sciences 2021; 22(11): 6088 doi: 10.3390/ijms22116088
|
| 54 |
Cindy CY Law, Conor Bell, Deborah Koh, Yueyang Bao, Vipul Jairath, Neeraj Narula. Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease. Cochrane Database of Systematic Reviews 2020; 2021(12) doi: 10.1002/14651858.CD013256.pub2
|
| 55 |
Lauren J. Mohan, Jacqueline S. Daly, Barbara M. Ryan, Zebunnissa Ramtoola. The future of nanomedicine in optimising the treatment of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2019; 54(1): 18 doi: 10.1080/00365521.2018.1563805
|
| 56 |
Milica Markovic, Karina Abramov-Harpaz, Clil Regev, Shimon Ben-Shabat, Aaron Aponick, Ellen M. Zimmermann, Yifat Miller, Arik Dahan. Prodrug-Based Targeting Approach for Inflammatory Bowel Diseases Therapy: Mechanistic Study of Phospholipid-Linker-Cyclosporine PLA2-Mediated Activation. International Journal of Molecular Sciences 2022; 23(5): 2673 doi: 10.3390/ijms23052673
|
| 57 |
|
| 58 |
Ira L. Leeds, Amy L. Lightner, Jacob A. Kurowski. Pediatric Inflammatory Bowel Disease. 2023; : 613 doi: 10.1007/978-3-031-14744-9_43
|
| 59 |
Jakub P. Piwowarski, Sebastian Granica, Anna K. Kiss. Lythrum salicaria L.—Underestimated medicinal plant from European traditional medicine. A review. Journal of Ethnopharmacology 2015; 170: 226 doi: 10.1016/j.jep.2015.05.017
|
| 60 |
Kin Man Au, Justin E. Wilson, Jenny P.-Y. Ting, Andrew Z. Wang. An injectable subcutaneous colon-specific immune niche for the treatment of ulcerative colitis. Nature Biomedical Engineering 2023; 8(10): 1243 doi: 10.1038/s41551-023-01136-9
|
| 61 |
Antonio López-Sanromán, Juan V. Esplugues, Eugeni Domènech. Farmacología y seguridad de tofacitinib en colitis ulcerosa. Gastroenterología y Hepatología 2021; 44(1): 39 doi: 10.1016/j.gastrohep.2020.04.012
|
| 62 |
Wissam Ghusn, Fadi H. Mourad, Fadi F. Francis, Shabana Pasha, Francis A. Farraye, Jana G. Hashash. The Use of Immunomodulators, Biologic Therapies, and Small Molecules in Patients With Inflammatory Bowel Disease and Solid Organ Transplant. Journal of Clinical Gastroenterology 2024; doi: 10.1097/MCG.0000000000002049
|
| 63 |
Sonia Shastri, Tanvi Shinde, Agampodi Promoda Perera, Nuri Gueven, Rajaraman Eri. Idebenone Protects against Spontaneous Chronic Murine Colitis by Alleviating Endoplasmic Reticulum Stress and Inflammatory Response. Biomedicines 2020; 8(10): 384 doi: 10.3390/biomedicines8100384
|
| 64 |
Yingying Liu, Ainsley M. Robinson, Xiao Qun Su, Kulmira Nurgali. Krill Oil and Its Bioactive Components as a Potential Therapy for Inflammatory Bowel Disease: Insights from In Vivo and In Vitro Studies. Biomolecules 2024; 14(4): 447 doi: 10.3390/biom14040447
|
| 65 |
Qing Ren, Bo Yang, Hao Zhang, R. Paul Ross, Catherine Stanton, Haiqin Chen, Wei Chen. c9, t11, c15-CLNA and t9, t11, c15-CLNA from Lactobacillus plantarum ZS2058 Ameliorate Dextran Sodium Sulfate-Induced Colitis in Mice. Journal of Agricultural and Food Chemistry 2020; 68(12): 3758 doi: 10.1021/acs.jafc.0c00573
|
| 66 |
Hyun Jin Jung, Ju-Hee Kang, Seongwon Pak, Keunwook Lee, Je Kyung Seong, Seung Hyun Oh. Detrimental Role of Nerve Injury-Induced Protein 1 in Myeloid Cells under Intestinal Inflammatory Conditions. International Journal of Molecular Sciences 2020; 21(2): 614 doi: 10.3390/ijms21020614
|
| 67 |
Suhyun Kim, Eun-Hye Hong, Cheol-Ki Lee, Yiseul Ryu, Hyunjin Jeong, Seungnyeong Heo, Joong-Jae Lee, Hyun-Jeong Ko. Amelioration of DSS-Induced Acute Colitis in Mice by Recombinant Monomeric Human Interleukin-22. Immune Network 2022; 22(3) doi: 10.4110/in.2022.22.e26
|
| 68 |
Shuang Yan, Bo Yang, R. Paul Ross, Catherine Stanton, Hao Zhang, Jianxin Zhao, Wei Chen. Bifidobacterium longum subsp. longum YS108R fermented milk alleviates DSS induced colitis via anti-inflammation, mucosal barrier maintenance and gut microbiota modulation. Journal of Functional Foods 2020; 73: 104153 doi: 10.1016/j.jff.2020.104153
|
| 69 |
Krista M. Reich, Richard N. Fedorak, Karen Madsen, Karen I. Kroeker. Role of Vitamin D in Infliximab-induced Remission in Adult Patients with Crohnʼs Disease. Inflammatory Bowel Diseases 2016; 22(1): 92 doi: 10.1097/MIB.0000000000000588
|
| 70 |
Qian-Wen LI, Wen LEI, Cong CHEN, Wei GUO. Recent advances of long noncoding RNAs involved in the development of multiple sclerosis. Chinese Journal of Natural Medicines 2020; 18(1): 36 doi: 10.1016/S1875-5364(20)30003-0
|
| 71 |
Rhian Stavely, Samy Sakkal, Vanesa Stojanovska, Kulmira Nurgali. Mesenchymal stem cells for the treatment of inflammatory bowel disease: from experimental models to clinical application. Inflammation and Regeneration 2014; 34(4): 184 doi: 10.2492/inflammregen.34.184
|
| 72 |
Suhyun Kim, Yun-Il Lee, Ki-Young Chang, Dong-Won Lee, Sung Chun Cho, Young Wan Ha, Ji Eun Na, Im Joo Rhyu, Sang Chul Park, Hae-Chul Park. Promotion of Remyelination by Sulfasalazine in a Transgenic Zebrafish Model of Demyelination. Molecules and Cells 2015; 38(11): 1013 doi: 10.14348/molcells.2015.0246
|
| 73 |
Wangyu Ye, Yuan Ding, Meng Li, Zhihua Tian, Shaoli Wang, Zhen Liu. Safety assessment of sulfasalazine: a pharmacovigilance study based on FAERS database. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1452300
|
| 74 |
Denise Sayuri Calheiros Silveira, Luciana Chain Veronez, Luís Carlos Lopes-Júnior, Elen Anatriello, Mariângela Ottoboni Brunaldi, Gabriela Pereira-da-Silva. <i>Lactobacillus bulgaricus </i>inhibits colitis-associated cancer via a negative regulation of intestinal inflammation in azoxymethane/dextran sodium sulfate model. World Journal of Gastroenterology 2020; 26(43): 6782-6794 doi: 10.3748/wjg.v26.i43.6782
|
| 75 |
Jiahong Li, Shiwen Yu, Xiaohua Pan, Ming Zhang, Zhuwu Lv, Li-Long Pan, Jia Sun. Recombinant CRAMP-producing Lactococcus lactis attenuates dextran sulfate sodium-induced colitis by colonic colonization and inhibiting p38/NF-κB signaling. Food & Nutrition Research 2021; 65 doi: 10.29219/fnr.v65.5570
|
| 76 |
Beining Li, Ping Hu, Hongyan Liang, Xingliang Zhao, Aiting Zhang, Yingchong Xu, Bin Zhang, Jie Zhang. Evaluating the causal effect of circulating proteome on the risk of inflammatory bowel disease-related traits using Mendelian randomization. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1434369
|
| 77 |
Mohammad Abbas Bejeshk, Amir Hashem Aminizadeh, Mohammad Amin Rajizadeh, Fahimeh Rostamabadi, Fatemeh Bagheri, Mohammad Khaksari, Maryam Azimi. Ameliorating effects of Acacia arabica and Ocimum basilicum on acetic acid-induced ulcerative colitis model through mitigation of inflammation and oxidative stress. Heliyon 2023; 9(11): e22355 doi: 10.1016/j.heliyon.2023.e22355
|
| 78 |
Heather C. Kaplan, Lisa Opipari-Arrigan, Jiabei Yang, Christopher H. Schmid, Christine L. Schuler, Shehzad A. Saeed, Kimberly L. Braly, Fandi Chang, Lauren Murphy, Cassandra M. Dodds, Mason Nuding, Hao Liu, Sheri Pilley, Julie Stone, Gisele Woodward, Nancy Yokois, Alka Goyal, Dale Lee, Ann Ming Yeh, Peter Lee, Benjamin D. Gold, Zarela Molle-Rios, R. Jeff Zwiener, Sabina Ali, Mallory Chavannes, Tiffany Linville, Ashish Patel, Travis Ayers, Mikelle Bassett, Brendan Boyle, Pablo Palomo, Sofia Verstraete, Jill Dorsey, Jess L. Kaplan, Steven J. Steiner, Kaylie Nguyen, Jennifer Burgis, David L. Suskind. Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease: A Series of N-of-1 Diet Trials. American Journal of Gastroenterology 2022; 117(6): 902 doi: 10.14309/ajg.0000000000001800
|
| 79 |
Kiyonori Kobayashi, Yasuo Suzuki, Kenji Watanabe, Kazunori Oda, Miyuki Mukae, Akihiro Yamada, Hirokazu Yamagami, Akira Nishimura, Hiroyuki Okamoto. A Phase 1, Multiple‐Dose Study of Vedolizumab in Japanese Patients With Ulcerative Colitis. The Journal of Clinical Pharmacology 2019; 59(2): 271 doi: 10.1002/jcph.1307
|
| 80 |
Adam F. Prasanphanich, Christopher T. Johnson, Andrey Krasnopeyev, Shraddha Cantara, Cristin Roach, Sanjeev Gumber, Raghavan Chinnadurai, Jacques Galipeau, Luke Brewster, J. David Prologo. Image-Guided Transarterial Directed Delivery of Human Mesenchymal Stem Cells for Targeted Gastrointestinal Therapies in a Swine Model. Journal of Vascular and Interventional Radiology 2019; 30(7): 1128 doi: 10.1016/j.jvir.2018.09.034
|
| 81 |
Adeola Temitope Salami, Gloria Enevwo Okotie, Precious Nekachi Echendu, Uwaifoh Akpamu, Samuel Babafemi Olaleye. Potassium bromate (KBrO3) modulates oxidative stress and inflammatory biomarkers in sodium hydroxide (NaOH) – induced Crohn’s colitis in Wistar rats. Canadian Journal of Physiology and Pharmacology 2021; 99(10): 989 doi: 10.1139/cjpp-2020-0678
|
| 82 |
Blanca Hernández-Ledesma, Samuel Fernández-Tomé, Lourdes Amigo. Bioactive Food Components Activity in Mechanistic Approach. 2022; : 155 doi: 10.1016/B978-0-12-823569-0.00010-2
|